BioSpace News Archive

Press Releases

Mythic Therapeutics to Present Compelling Efficacy Data from Phase 1 KisMET-01 Study Supporting Best-in-Class Potential of Investigational cMET ADC, MYTX-011, in Non-Small Cell Lung Cancer

May 23, 2025
·
2 min read
Press Releases

MiraDx Announces New Research Conducted in Collaboration with UCLA and Accepted for Presentation at ASCO 2025 that Highlights the Role of MicroRNA-based Genetic Signatures in Predicting Radiation and Immunotherapy Treatment-Related Outcomes

May 23, 2025
·
3 min read
Press Releases

Daiichi Sankyo Continues to Transform Treatment Landscape for Patients with Cancer with Practice-Changing Data at ASCO

May 23, 2025
·
12 min read
Press Releases

Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC

May 23, 2025
·
8 min read
Press Releases

RWJBarnabas Health and Rutgers Cancer Institute to Present Practice-Changing Research at 2025 ASCO Annual Meeting

May 23, 2025
·
5 min read
Press Releases

Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025

May 23, 2025
·
13 min read
Press Releases

Rakuten Medical Announces Trial in Progress Poster Presentation at ASCO 2025 and Enrollment Expansion to Taiwan for Global Phase 3 ASP-1929-381

May 23, 2025
·
7 min read
Press Releases

Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock

May 23, 2025
·
5 min read
Press Releases

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting

May 23, 2025
·
14 min read
Press Releases

Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025

May 23, 2025
·
7 min read